Testing for human papillomavirus and measurement of viral load of HPV 16 and 18 in self-collected vaginal swabs of women who do not undergo cervical cytological screening in Southern France

Journal of Medical Virology

Volumn 82, Issue 8, 2010, Pages 1431-1437

  Tamalet, Catherine ^a   Richet, Hervé ^a   Carcopino, Xavier ^b   Henry, Mireille ^a   Leretraite, Laurence ^c   Heid, Patrice ^c   Leandri, François Xavier ^c   Sancho Garnier, Hélène ^d   Piana, Lucien ^c  

^a TIMONE HOSPITAL   (France)

^b HÔPITAL NORD   (France)

^c Parc Mure BatA   (France)

^d CENTRE VAL D AURELLE   (France)

Author keywords

Cervical cancer; High risk and low risk HPV types; Human papillomavirus; Low economic class women; Self obtained vaginal swabs; Viral load

Indexed keywords

VIRUS DNA;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; FRANCE; GENOTYPE; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 26; HUMAN PAPILLOMAVIRUS TYPE 31; HUMAN PAPILLOMAVIRUS TYPE 53; HUMAN PAPILLOMAVIRUS TYPE 58; HUMAN PAPILLOMAVIRUS TYPE 61; HUMAN PAPILLOMAVIRUS TYPE 66; HUMAN PAPILLOMAVIRUS TYPE 70; HUMAN PAPILLOMAVIRUS TYPE 81; IMMIGRANT; PAPILLOMA VIRUS; PAPILLOMAVIRUS INFECTION; PREVALENCE; RISK ASSESSMENT; SCREENING TEST; UTERINE CERVIX CYTOLOGY; VAGINA SMEAR; VIRUS DETECTION; VIRUS LOAD; DRUG SELF ADMINISTRATION; EVALUATION STUDY; ISOLATION AND PURIFICATION; MASS SCREENING; MIDDLE AGED; PAPILLOMAVIRUS INFECTIONS; PROCEDURES; VAGINA; VIROLOGY;

ADULT; AGED; FEMALE; FRANCE; HUMAN PAPILLOMAVIRUS 16; HUMAN PAPILLOMAVIRUS 18; HUMANS; MASS SCREENING; MIDDLE AGED; PAPILLOMAVIRUS INFECTIONS; PREVALENCE; SELF ADMINISTRATION; VAGINA; VIRAL LOAD;

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 16;

EID: 77956602672     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.21835     Document Type: Article

References (49)

1. Agarossi A, Ferrazzi E, Parazzini F, Perno CF, Ghizoni L. 2009. Prevalence and type distribution of high-risk human papillomavirus infection in women undergoing voluntary cervical cancer screening in Italy. J Med Virol 81:529-535.
2. Aubin F, Prétet JL, Jacquard AC, Saunier M, Carcopino X, Jaroud F, Pradat P, Soubeyrand B, Leocmach Y, Mougin C, Riethmuller D, EDiTH Study Group. 2008. Human papillomavirus genotype distribution in external acuminata condylomata: A Large French National Study (EDiTH IV). Clin Infect Dis 47:610-615.
3. Baay M, Smits E, Tjalma WAA, Lardon F, Weyler J, Van Royen P, Van Marck EAE, Vermoken JB. 2004. Can cervical cancer screening be stopped at 50? The prevalence of HPV in elderly women. Int J Cancer 108:258-261.
4. Bais AG, Van Kemenade FJ, Berkhof J, Verheijen RH, Snijders PJ, Voohorst F, Balovic M, Van Ballegooigen M, Helmerhorst JJ, Meijer CJ. 2007. Human papillomavirus testing on self sampled cervicovaginal brushes: An effective alternative to protect non-responders in cervical screening programs. Int J Cancer 120:1505-1510.
5. Bosch FX, lorincz A, Munoz N, Meijer CJ, Shah KV. 2002. The causal relation between human papillomavirus and cervical cancer. J Clin Pathol 55:244-265.
6. Brinck A, Meijer C, Wiegerinck M, Nieboer TE, Kruitwagen R, Van Kemenade F, Daalmeijer N, Hesselink AT, Berkhof J, Snijders P. 2006. High concordance of results of testing for human papillomavirus in cervicovaginal samples collected by two methods with comparison of novel self-sampling device to a conventional endocervical brush. J Clin Microbiol 44:2518-2523.
7. Bulkmans NW, Berkhof J, Rozendaal L, van Kemenade FJ, Boeke AJ, Bulk S, Voorhorst FJ, Verheijen RH, van Groningen K, Boon ME, Ruitinga W, van Ballegooijen M, Snijders PJ, Meijer CJ. 2007. Human papillomavirus DNA testing for the detection of cervical intraepithelial neoplasia grade 3 and cancer: 5-year follow-up of a randomised controlled implementation trial. Lancet 370:1764-1772.
8. Carcopino X, Henry M, Benmoura D, Fallabregues AS, Richet H, Boubli L, Tamalet C. 2006. Determination of HPV type 16 and 18 viral load in cervical smears of women referred to colposcopy. J Med Virol 78:1131-1140.
9. Cuzick J, Szarewski A, Terry G, Ho L, Hanby A, Maddox P, Anderson M, Kocjan G, Steele ST, Guillebaud J. 1995. Human papillomavirus testing in primary cervical screening. Lancet 345:1533-1536.
10. Daponte A, Tsezou A, Oikonomou P, Hadjichristodoulou C, Maniatis AN, Pournaras S, Messinis IE. 2008. Use of real-time PCR to detect human papillomavirus-16 viral loads in vaginal and urine self-sampled specimens. Clin Microbiol Infect 14:619-621. (Pubitemid 351639082)
11. de Sanjosé S, Diaz M, Castellsagué X, Clifford G, Bruni L, Muñoz N, Bosch FX. 2007. Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: A meta-analysis. Lancet Infect Dis 7:453-459.
12. Franco EL, Schlecht NF, Saaslow D. 2003. The epidemiology of cervical cancer. Cancer J 9:348-359.
13. Gravitt PE, Lacey JV, Brinton LA, Barnes WA, Kornegay JR, Greenberg MD, Greene SM, Hadjimichael OC, McGowan L, Mortel R, Schwartz PE, Zaino R, Hildesheim A. 2001. Evaluation of self-collected cervicovaginal cell samples for human papillomavirus testing by polymerase chain reaction. Cancer Epidemiol Biomarkers Prev 10:95-100.
14. Gravitt PE, Kovacic MB, Herrero R, Schiffman M, Bratti C, Hildesheim A, Morales J, Alfaro M, Sherman ME, Wacholder S, Rodriguez AC, Burk RD. 2007. High load for most high risk human papillomavirus genotypes is associated with prevalent cervical cancer precursors but only HPV16 load predicts the development of incident disease. Int J Cancer 121:2787-2793. (Pubitemid 350136428)
15. Harper DM, Franco EL, Wheeler CM, Moscicki AB, Romanowski B, Roteli-Martins CM, Jenkins D, Schuind A, Costa Clemens SA, Dubin G. 2006. Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: Follow-up from a randomised control trial. Lancet 367:1247-1255.
16. Herrero R, Schiffman MH, Bratti C, Hildesheim A, Balmaceda I, Sherman ME, Greenberg M, Cardenas F, Gomez V, Helgesen K, Morales J, Hutchinson M, Mango L, Alfaro M, Potischman NW, Wacholder S, Swanson C, Brinton LA. 1997. Design and methods of a population-based natural history study of cervical neoplasia in a rural province of Costa Rica: The Guanacaste project. Pan Am Rev Raham Salud Cublica 286:362-375. (Pubitemid 27428425)
17. Hillemanns P, Kimmig R, Huttemann U, Dannecker C, Thaler CJ. 1999. Screening for cervical neoplasia by self-assessment for human papillomavirus DNA. Lancet 354:1970.
18. Ho GY, Bierman R, Beardsley L, Chang CJ, Burk RD. 1998. Natural history of cervicovaginal papillomavirus infection in young women. N Engl J Med 338:423-428.
19. Holanda F, Castelo A, Veras TM, de Almeida FM, Lins MZ, Dores GB. 2006. Primary screening for cervical cancer through self-sampling. Int J Gynaecol Obstet 95:179-184. (Pubitemid 44635514)
20. Josefsson AM, Magnusson PK, Ylitalo N, Sorensen P, Qwarforth-Tubbin P, Andersen PK, Melbye M, Adami HO, Gyllensten UB. 2000. Viral load of human papillomavirus 16 as a determinant for development of cervical carcinoma in situ: A nested case-control study. Lancet 355:2189-2193. (Pubitemid 30394325)
21. Karwalajtys T, Howard M, Sellors JW, Kaczorowski J. 2006. Vaginal self-sampling versus physician cervical sampling for HPV among younger and older women. Sex Transm Infect 82:337-339.
22. Khan MJ, Castle PE, Lorincz AT, Wacholder S, Sherman M, Scott DR, Rush BB, Glass AG, Schiffman M. 2005. The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice. J Natl Cancer Inst 14:1072-1079.
23. Kitchener HC, Almonte M, Wheeler P, Dessai M, Gilham C, Bailey A, Sargent A, Peto J. 2006. HPV testing in routine cervical screening: Cross sectional data from the ARTISTIC trial. Br J Cancer 95:56-61. (Pubitemid 43980554)
24. Levert M, Clavel C, Graesslin O, Birembaut P, Quereux C, Gabriel R. 2000. Human papillomavirus typing in routine cytological screening: Results of an investigation on 3778 patients. Gynecol Obstet Fertil 28:722-728.
25. Lindau ST, Drum ML, Gaumer E, Surawska H, Jordan JA. 2008. Prevalence of high-risk human papillomavirus among older women. Obstet Gynecol 112:979-989.
26. Mayrand MH, Duarte-Franco E, Rodrigues I, Walter SD, Hanley J, Ferenczy A, Ratnam S, Coutlée F, Franco EL. 2007. Human papillomavirus DNA versus Papanicolaou screening tests for cervical cancer. N Engl J Med 357:1579-1588.
27. Melkert PW, Hopman E, Van den Brule AJC, Risse EKJ, Van Diest PJ, Bleker OP, Helmerhorst T, Schipper ME, Meijer CJ, Walboomers JM. 1993. Prevalence of HPV in cytomorphologically normal cervical smears, as determined by the polymerase chain reaction is age-dependent. Int J Cancer 53:919-923.
28. Monnier-Benoit S, Dalstein V, Riethmuller D, Lalaoui N, Mougin C, Pretet JL. 2006. Dynamics of HPV16 load reflect the natural history of cervical HPV-associated lesions. J Clin Virol 35:270-277. (Pubitemid 43188972)
29. Munoz N, Kato I, Bosch FX, Eluf-neto J, de Sanjose S, Asunce N, Viladiu P, Tormo MJ, Moreo P, Gonzalez LC, Tafur L, Gili M, Izarzugaza I, Walboomers JM, Shah KV. 1996. Risk factors for HPV detection in middle-aged women. Sex Transm Dis 23:504-510.
30. Munoz N, Castellsagne X, Berrington de Gonzalez, Gissmann L. 2006. HPV in the etiology of human cancer. Vaccine 53;S3/1-S3/10.
31. Naucler P, Ryd W, Törnberg S, Strand A, Wadell G, Elfgren K, Râdberg T, Strander B, Forslund O, Hansson B, Rylander E, Dillner J. 2007. Human papillomavirus and Papanicolaou tests to screen for cervical cancer. N Engl J Med 357:1589-1597.
32. Nicollas R, Henry M, Triglia JM, Tamalet C. 2007. HPV type 6 and 16 co-infection in a 11-year-old girl presenting laryngeal papillomatosis. J Clin Virol 40:252-254. (Pubitemid 47552924)
33. Nielsen A, Kjaer SK, Munk C, Iftner T. 2008. Type-specific HPV infection and multiple HPV types: Prevalence and risk factor profile in nearly 12,000 younger and older Danish women. Sex Transm Dis 35:276-282. (Pubitemid 351619532)
34. Nobbenhuis MA, Walboomers JMM, Helmhorst TJM, Rozebdaal L, Remmink AJ, Risse EKJ, Van der Linden HC, Voorhorst FJ, Kenemans P, Meijer CJ. 1999. Relation of human papillomavirus status to cervical lesions and consequences for cervical cancer screening: A prospective study. Lancet 354:20-25.
35. Paavonen J, Jenkins D, Bosch FX, Naud P, Salmeron J, Wheeler CM, Chow SN, Apter DL, Kitchener HC, Castellsague X, de Carvalho NS, Skinner SR, Harper DM, Hedrick JA, Jaimsarn U, Limson GA, Dionne M, Quint W, Spiessens B, Peeters P, Struyf F, Wieting SL, Lehtinen MO, Dubin G, HPV PATRICIA study group. 2007. Efficacy of a prophylactic adjuvant bivalent L1 virus-like particle vaccine against infection with human papillomavirus types 16 and 18 in young women: An interim analysis of a phase III double-blind, randomised controlled trial. Lancet 369:2161-2170.
36. Petignat P, Hankins C, Walmsley S, Money D, Provencher D, Pourreaux K, Kornegay J, Rouah F, the Canadian Women's HIV study group, Coutlee F, 2005. Self-sampling is associated with increased detection of human papillomavirus DNA in the genital tract of HIV-seropositive women. Clin Infect Dis 41:527-534. (Pubitemid 41099649)
37. Petignat P, Faltin DL, Bruchim I, Tramer MR, Franco EL, Coutlée F. 2007. Are self-collected samples comparable to physician-collected cervical specimens for human papillomavirus DNA testing? A systematic review and meta-analysis. Gynecol Oncol 105:530-535. (Pubitemid 46590347)
38. Piana L, Leandri FX, Jacqueme B, Heid P, Corti J, Andrac-Meyer L, Sancho-Garnier H. 2007. Organized cervical cancer screening for underpriviledged women. Bull Cancer 94:461-467.
39. Remontet L, Buerni A, Velten M, Jougla E, Esteve J. 2003. In: Saint-Maurice, Institut de Veille Sanitaire editor. Evolution de l'incidence et de la mortalité par cancer en France de 1978 à 2000. 2003. Institut de Veille Sanitaire, Paris, Editor. pp 107-112.
40. Ronco G, Giorgi-Rossi P, Carozzi F, Confortini M, Dalla Palma P, Del Mistro A, Gillio-Tos A, Minucci D, Naldoni C, Riszzolo R, Schincaglia P, Volante R, Zappa M, Zorzi M, Cuzick J, Segnan N. 2008. For the new technologies for cervical cancer working group. Results as recruitment from a randomized controlled trial comparing human papillomavirus testing alone with conventional cytology as the primary cervical screening test. J Natl Cancer Inst 100:492-501.
41. Saunier M, Monnier-Benoit S, Mauny F, Dalstein V, Briolat J, Riethmuller D. 2008. Analysis of human papillomavirus type 16 (HPV16) DNA load and physical state for identification of HPV16-infected women with high-grade lesions or cervical carcinoma. J Clin Microbiol 46:3678-3685.
42. Sawaya GF, Washington AE. 1999. Cervical cancer screening: Which techniques should be used and why? Clin Obstet Gynecol 42:922-938.
43. Schaffer P, Sancho-Garnier H, Fender M, Dellenbach P, Carbillet JP, Monnet E, Gauthier GP, Garnier A. 2000. Cervical cancer screening in France. Eur J Cancer 36:2215-2220.
44. Sellors JW, Lorincz AT, Mahony JB, Mielzynska I, Lytwyn A, Roth P, Howard M, Chong S, Daya D, Chapman W, Chenersky M. 2000. Comparison of self-collected vaginal, vulvar and urine samples with physician-collected cervical samples for human papillomavirus testing to detect high-grade squamous intraepithelial lesions. JAMA 163:513-518.
45. Sellors JW, Karwalajtys TL, Kaczorowski JA, Mahony JA, Lytwyn A, Chong S, Sparrow J, Lorincz A, Survey of HPV in Older Ontario Woomen (SHOOW Group). 2002. Prevalence of infection with carcinogenic human papillomavirus among older women. JAMA 167:871-873.
46. Stenvall H, Wikstrom I, Backlund I, Wilander E. 2007. Accuracy of HPV testing of vaginal smear obtained with a novel self-sampling device. Acta Obstet Gynecol Scand 86:16-21. (Pubitemid 46009520)
47. Van der Graaf Y, Molijn A, Doornewaard H, Quint W, Van Doorn LJ, Vanden Tweel J. 2002. Human papillomavirus and the long-term risk of cervical neoplasia. Am J Epidemiol 156:158-164. (Pubitemid 34755954)
48. Woodman CB, Collins S, Winter H, Bailey A, Ellis J, Prior P, Yates M, Rollason TP, Young LS. 2001. Natural history of cervical human papillomavirus infection in young women: A longitudinal cohort study. Lancet 357:1831-1836.
49. Wright TC, Denny L, Kuhn L, Pollack A, Lorincz A. 2000. HPV DNA testing of self-collected vaginal samples compared with cytologic screening to detect cervical cancer. JAMA 283:81-86. (Pubitemid 30038387)